Related Experiment Videos
Peptide immunization excludes antigen-specific T cells from splenic lymphoid compartments.
Lei Zhang1, Elaine F Lizzio, Trina Chen
1Division of Monoclonal Antibodies, Office of Biotechnology Products, Office of Pharmaceutical Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, USA.
European Journal of Immunology
|February 17, 2005
Summary
Peptide vaccines lead T cells to the red pulp and increase apoptosis, unlike protein vaccines. Linking peptides to carrier proteins improves T cell homing and reduces cell death, enhancing vaccine responses.
Area of Science:
- Immunology
- Vaccinology
Background:
- Understanding T cell homing to splenic compartments is crucial for vaccine development.
- Distinct immune responses are observed with peptide versus whole-protein antigens.
Purpose of the Study:
- To investigate the splenic homing patterns of T cells after immunization with peptide or whole-protein antigens.
- To assess the impact of antigen form on T cell apoptosis and cytokine production.
- To explore strategies for improving peptide vaccine efficacy.
Main Methods:
- Adoptive transfer of TCR-transgenic T cells in mice.
- Systemic immunization with peptide or protein antigen.
- In situ assessment of T cell location, cytokine production, cell surface markers, and apoptosis.
Main Results:
- CD4(+) T cells showed distinct splenic homing: peptide immunization led to red pulp localization, while whole-protein immunization resulted in white pulp localization.
- Peptide immunization significantly increased Fas ligand expression and T cell apoptosis compared to whole-protein immunization.
- Cytokine production (IL-4, IL-2, IFN-gamma) and localization to the splenic white pulp were observed only with whole-protein immunization.
- Linking a peptide epitope to a carrier protein improved white pulp T cell localization and reduced apoptosis.
Conclusions:
- The unique homing and increased apoptosis following peptide immunization may explain the limited effectiveness of peptide vaccines.
- Conjugating peptide antigens to carrier proteins represents a viable strategy to enhance T cell localization and reduce apoptosis, thereby improving vaccine responses.